-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 GH3M2Ty8kTfDjcH6K4hb790C3HY4Y6cBLYkFIn+1GBEzvWyTYpmoUl/6YktqwCcE
 t0cfVqwr39qgdvzZpmIBsw==

<SEC-DOCUMENT>0001308037-10-000007.txt : 20100303
<SEC-HEADER>0001308037-10-000007.hdr.sgml : 20100303
<ACCEPTANCE-DATETIME>20100303140529
ACCESSION NUMBER:		0001308037-10-000007
CONFORMED SUBMISSION TYPE:	D/A
PUBLIC DOCUMENT COUNT:		1
ITEM INFORMATION:		Rule 506
FILED AS OF DATE:		20100303
DATE AS OF CHANGE:		20100303
EFFECTIVENESS DATE:		20100303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CytomX Therapeutics, LLC
		CENTRAL INDEX KEY:			0001465584
		IRS NUMBER:				261870083
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		D/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	021-131732
		FILM NUMBER:		10652717

	BUSINESS ADDRESS:	
		STREET 1:		460 WARD DRIVE, STE. E-1
		CITY:			SANTA BARBARA
		STATE:			CA
		ZIP:			93111
		BUSINESS PHONE:		805-964-9700

	MAIL ADDRESS:	
		STREET 1:		460 WARD DRIVE, STE. E-1
		CITY:			SANTA BARBARA
		STATE:			CA
		ZIP:			93111
</SEC-HEADER>
<DOCUMENT>
<TYPE>D/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<edgarSubmission>

    <schemaVersion>X0603</schemaVersion>

    <submissionType>D/A</submissionType>

    <testOrLive>LIVE</testOrLive>

    <primaryIssuer>
        <cik>0001465584</cik>
        <entityName>CytomX Therapeutics, LLC</entityName>
        <issuerAddress>
            <street1>460 WARD DRIVE, STE. E-1</street1>
            <city>SANTA BARBARA</city>
            <stateOrCountry>CA</stateOrCountry>
            <zipCode>93111</zipCode>
        </issuerAddress>
        <issuerPhoneNumber>805-964-9700</issuerPhoneNumber>
        <jurisdictionOfInc>CALIFORNIA</jurisdictionOfInc>
        <issuerPreviousNameList>
            <value>None</value>
        </issuerPreviousNameList>
        <edgarPreviousNameList>
            <value>None</value>
        </edgarPreviousNameList>
        <entityType>Limited Liability Company</entityType>
        <yearOfInc>
            <withinFiveYears>true</withinFiveYears>
            <value>2008</value>
        </yearOfInc>
    </primaryIssuer>

    <relatedPersonsList>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Nancy</firstName>
                <lastName>Stagliano</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>460 Ward Drive, Ste. E-1</street1>
                <city>Santa Barbara</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>93111</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>President and Manager on Board</relationshipClarification>
        </relatedPersonInfo>
        <relatedPersonInfo>
            <relatedPersonName>
                <firstName>Michael</firstName>
                <middleName>E.</middleName>
                <lastName>Pfau</lastName>
            </relatedPersonName>
            <relatedPersonAddress>
                <street1>1421 State Street, Ste. B</street1>
                <city>Santa Barbara</city>
                <stateOrCountry>CA</stateOrCountry>
                <zipCode>93101</zipCode>
            </relatedPersonAddress>
            <relatedPersonRelationshipList>
                <relationship>Executive Officer</relationship>
            </relatedPersonRelationshipList>
            <relationshipClarification>Secretary</relationshipClarification>
        </relatedPersonInfo>
    </relatedPersonsList>

    <offeringData>
        <industryGroup>
            <industryGroupType>Other Technology</industryGroupType>
        </industryGroup>
        <issuerSize>
            <revenueRange>Not Applicable</revenueRange>
        </issuerSize>
        <federalExemptionsExclusions>
            <item>06</item>
        </federalExemptionsExclusions>
        <typeOfFiling>
            <newOrAmendment>
                <isAmendment>true</isAmendment>
                <previousAccessionNumber>0001465584-09-000003</previousAccessionNumber>
            </newOrAmendment>
            <dateOfFirstSale>
                <value>2009-06-01</value>
            </dateOfFirstSale>
        </typeOfFiling>
        <durationOfOffering>
            <moreThanOneYear>false</moreThanOneYear>
        </durationOfOffering>
        <typesOfSecuritiesOffered>
            <isOptionToAcquireType>true</isOptionToAcquireType>
            <isOtherType>true</isOtherType>
            <descriptionOfOtherType>Convertible Note and Warrant Offering</descriptionOfOtherType>
        </typesOfSecuritiesOffered>
        <businessCombinationTransaction>
            <isBusinessCombinationTransaction>false</isBusinessCombinationTransaction>
            <clarificationOfResponse></clarificationOfResponse>
        </businessCombinationTransaction>
        <minimumInvestmentAccepted>1000</minimumInvestmentAccepted>
        <salesCompensationList></salesCompensationList>
        <offeringSalesAmounts>
            <totalOfferingAmount>2500000</totalOfferingAmount>
            <totalAmountSold>2500000</totalAmountSold>
            <totalRemaining>0</totalRemaining>
            <clarificationOfResponse>The Company increased its offering size from $1,750,000 to $2,500,000</clarificationOfResponse>
        </offeringSalesAmounts>
        <investors>
            <hasNonAccreditedInvestors>false</hasNonAccreditedInvestors>
            <totalNumberAlreadyInvested>19</totalNumberAlreadyInvested>
        </investors>
        <salesCommissionsFindersFees>
            <salesCommissions>
                <dollarAmount>0</dollarAmount>
            </salesCommissions>
            <findersFees>
                <dollarAmount>0</dollarAmount>
            </findersFees>
            <clarificationOfResponse></clarificationOfResponse>
        </salesCommissionsFindersFees>
        <useOfProceeds>
            <grossProceedsUsed>
                <dollarAmount>0</dollarAmount>
            </grossProceedsUsed>
            <clarificationOfResponse>Proceeds will be used for working capital</clarificationOfResponse>
        </useOfProceeds>
        <signatureBlock>
            <authorizedRepresentative>false</authorizedRepresentative>
            <signature>
                <issuerName>CytomX Therapeutics, LLC</issuerName>
                <signatureName>/s/ Michael E. Pfau</signatureName>
                <nameOfSigner>Michael E. Pfau</nameOfSigner>
                <signatureTitle>Secretary</signatureTitle>
                <signatureDate>2010-03-03</signatureDate>
            </signature>
        </signatureBlock>
    </offeringData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----